Sahajanand Medical Technologies IPO Day 3: Subscription Closes Today, 19 October 2026

Sahajanand Medical Technologies IPO closes today, 19 Oct 2026. Subscribed 0.83x through Day 2: QIB 1.12x, Retail 0.83x, NII 0.51x.

Updated: 19 Oct 2026 • 1:24 am

Posted by:

Quick Answer

The Sahajanand Medical Technologies IPO is on its final day of bidding on 19 October 2026. The issue climbed from 0.35 times at the Day 1 close to 0.83 times at the Day 2 close on 16 October, with QIB at 1.12 times excluding the anchor portion, retail at 0.83 times and NII at 0.51 times. With bidding open until the end of today's session, the final subscription figure depends on demand in the closing hours.

Sahajanand Medical Technologies Limited, a Surat-based medical devices maker, has reached the final day of its IPO subscription window today, 19 October 2026. The Sahajanand Medical Technologies IPO opened on 15 October 2026 and is a mainboard, book built issue worth about Rs 475.48 crore, entirely an offer for sale. The shares are proposed to list on BSE and NSE.

Bidding resumes today after the weekend. Day 2 bids were for about 80.62 lakh shares against roughly 97.50 lakh shares on offer to the public, from about 82,500 applications. QIB bids of about 30.49 lakh shares exceeded the 27.14 lakh share quota, while small NII bidders were at 0.77 times and big NII bidders at 0.38 times.

Click Here – Get Free Investment Predictions

Table of Contents

Sahajanand Medical Technologies IPO Details

The table below sets out the key parameters of the Sahajanand Medical Technologies IPO.

Open Date	15 October 2026
Close Date	19 October 2026
Face Value	Re 1 per share
Price Band	Rs 327 to Rs 344 per share
Lot Size	43 shares
Issue Size	Rs 475.48 crore (entirely offer for sale)
Issue Type	Book Built Issue, Mainboard
Listing At	BSE, NSE
Allotment Date	21 October 2026
Listing Date	23 October 2026

Sahajanand Medical Technologies IPO Subscription Status Day 3

The table below tracks how the issue has moved through its bidding window, from the Day 1 close through to the Day 2 reading on Friday, 16 October.

Session	Overall	QIB	NII	Retail
Day 1 close (15 Oct)	0.35x	0.37x	0.20x	0.41x
Day 2 close (16 Oct)	0.83x	1.12x	0.51x	0.83x
Day 3, closing day so far (19 Oct)	Updating through the session

NII was still the softest segment at 0.51 times, and large bids in mainboard issues often arrive in the final hours. Figures are the NSE reading at about 5 PM on 16 October, so confirm final numbers on NSE or BSE once bidding closes today.

Track Subscription Status for the issue on the Univest Screener

How to Apply for the Sahajanand Medical Technologies IPO

Open a Demat and trading account with a SEBI-registered broker such as Univest if you do not already have one.
Select the issue on your broker app or net banking platform and enter your bid quantity and price within the Rs 327 to Rs 344 band, in multiples of 43 shares.
Submit the application through the UPI-based ASBA method so the bid amount is blocked rather than debited immediately.
Approve the UPI mandate on your phone before the daily cut off time, since the issue closes for good after this session.

Download the Univest iOS App or Univest Android App to apply for the issue before it closes today.

Grey market premium (GMP) is an unofficial, unregulated indicator for the issue that is not endorsed by SEBI, NSE, or BSE. Investors looking for indicative GMP data can go through other relevant sources, though such figures should never be the sole basis for an investment decision.

Conclusion

The issue closes today with the overall book at 0.83 times through Day 2, with QIB already past its quota. Investors considering the issue should weigh the valuation against listed peers such as Poly Medicure and the pricing pressure on stents, and read the RHP on bseindia.com before applying after independent due diligence before the window shuts today.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs

What is the Sahajanand Medical Technologies IPO subscription status on Day 3?

Ans. On the closing day, 19 October 2026, the issue carries forward a Day 2 reading of 0.83 times overall, with QIB at 1.12 times, retail at 0.83 times and NII at 0.51 times, and figures are updating through today's final session.

When does the Sahajanand Medical Technologies IPO close?

Ans. The issue closes for subscription today, 19 October 2026, having opened on 15 October 2026.

What is the Sahajanand Medical Technologies IPO price band and lot size?

Ans. The issue price band is Rs 327 to Rs 344 per share, with a lot size of 43 shares. A retail investor needs at least one lot, which is about Rs 14,792 at the upper price band.

Is the Sahajanand Medical Technologies IPO fully subscribed?

Ans. Not yet. The issue stood at 0.83 times after Day 2, with QIB at 1.12 times excluding the anchor portion, retail at 0.83 times and NII at 0.51 times, and the final figure will be confirmed once bidding closes today.

What is the Sahajanand Medical Technologies IPO GMP?

Ans. Grey market premium (GMP) is an unofficial, unregulated indicator for the issue that is not endorsed by SEBI, NSE, or BSE. Investors looking for indicative GMP data can go through other relevant sources, though such figures should never be the sole basis for an investment decision.

How do I apply for the Sahajanand Medical Technologies IPO?

Ans. You can apply for the issue through your SEBI-registered broker or UPI-enabled banking app using the ASBA method, enter your bid quantity and price within the Rs 327 to Rs 344 band, in multiples of 43 shares, then approving the UPI mandate before the daily cut off.

When will the Sahajanand Medical Technologies IPO be allotted and listed?

Ans. The issue allotment is expected to be finalised on 21 October 2026, with listing on BSE and NSE tentatively scheduled for 23 October 2026.

What does Sahajanand Medical Technologies Limited do?

Ans. Sahajanand Medical Technologies Limited makes Class III and Class C and D medical devices, mainly for vascular and structural heart intervention, and is based in Surat.